HSBC Holdings
CALA

HSBC Holdings’s Calithera Biosciences, Inc CALA Stock Holding History

HSBC Holdings’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-660
Closed -$5K – 3541
2022
Q1 		$5K Hold
660
– – ﹤0.01% 3244
2021
Q4 		$9K Buy
660
+14
+2% +$352 ﹤0.01% 3238
2021
Q3 		$28K Sell
646
-94
-13% -$4.05K ﹤0.01% 2949
2021
Q2 		$30K Buy
740
+1
+0.1% +$44 ﹤0.01% 2899
2021
Q1 		$36K Buy
739
+236
+47% +$13.7K ﹤0.01% 2676
2020
Q4 		$50K Buy
+503
New +$44.1K ﹤0.01% 2989

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings's CALA Position: Q2 2022 in Review

HSBC Holdings sold out of Calithera Biosciences, Inc (CALA) in Q2 2022, closing a stake of 660 shares — an estimated $5K sold.

HSBC Holdings first reported a position in CALA in Q4 2020 and held it in 6 quarters. The position peaked at $50K in Q4 2020. 28 funds tracked by Wall St. Rank hold CALA as of Q2 2022.

  • HSBC Holdings reported no remaining Calithera Biosciences, Inc position as of Q2 2022 after selling out during the quarter.
  • HSBC Holdings sold 660 Calithera Biosciences, Inc shares in Q2 2022, an estimated $5K.
  • HSBC Holdings first reported a position in Calithera Biosciences, Inc in Q4 2020 and held it in 6 quarters.
  • HSBC Holdings's Calithera Biosciences, Inc position peaked at $50K in Q4 2020.
  • 28 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2022.

Based on HSBC Holdings's 13F filing for Q2 2022, filed 11 Aug 2022.